Skip to main content
Caplight Logo









Moleculera Biosciences

Moleculera Biosciences

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://www.moleculera.com/

Last Round

Series A

May 21, 2025

Total Funding Raised

$4.2M

Company Overview

Moleculera Biosciences is a laboratory services (healthcare) company that provides personalized clinical testing services intended to offer molecular diagnostic testing for autoimmune neuroimmunology.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials, Medical AI

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

Autoimmune Brain PanelCunningham PanelPANS/PANDAS diagnosisautoimmune diagnosticsprecision medicineautoantibody testinginfection-triggered disordersautoimmune neurologyCLIA-certified laboratorybiorepository servicespharma clinical trial servicesautoimmune cardiovascular panelAI treatment prediction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Moleculera Biosciences Comparables

Compare Moleculera Biosciences with similar companies based on industry and business-model similarity.

Moleculera Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZeiniX Life Sciences
80%
Mitogen Diagnostics
77%
GLX Analytix
71%

Moleculera Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 21, 2025
GrantOct 30, 2024
GrantJan 11, 2024
GrantJul 7, 2015
SeedMay 20, 2015

Key People

Founding team and executive leadership

Craig Shimasaki

President & CEO

Executive Team

Moleculera Biosciences Investors

Notable investors and investment history

Moleculera Biosciences investors
InvestorRounds
i2ESeed
SeedStep AngelsSeed
Oklahoma Center for the Advancement of Science and TechnologyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 27, 2025

    Monthly visitors increased 47% MoM, reaching 15.7K.

  • Nov 9, 2024

    Monthly visitors grew 41% MoM, reaching 18.3K.

Moleculera Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Moleculera Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Moleculera Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range13
Year Founded2011
Last FundingMay 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?